We evaluated a new, fast, quantitative, turbidimetric assay (TurbiTimeSystem, Behringwerke AG, Marburg, Germany) for the determination of myoglobin concentration in serum. Within-run imprecision (n = 10) was < 3.7% in controls ranging from 81.1 to 621.4 g/l and between-day imprecision (n = 50) was < 6% in controls ranging from 69.5 to 623.4 g/l. The assay is linear over the measuring ränge and interfering substances such äs bilirübin, haemoglobin or haptoglobin do not interfere but triacylglycerol-rich samples are only measureable after brief ultracentrifugation. EDTA-or citrate-treated samples display depressed myoglobin concentration when compared with serum samples. The upper reference limit for apparently healthy individuals (n = 100, 50 female and 50 male) is 61.5 g/l. Comparison with nephelometry revealed a good correlation (r = 0.982) between the two methods with the regression equation: turbidimetric assay = 5.53 4-1.02x nephelometric assay.
Introduction
nosis of acute myocardial infarction (6) . In the routine clinical chemistry laboratory, myoglobin concentrations Myoglobin is a low-molecular mass, oxygen-binding can be determined by ra dioimmunoassay (7, 8) or imhaemoprotein (M r 17700) of the skeletal and cardiac munonephelometry (9) . ^ methods m sens itive but muscle (1) . Elevation of the myoglobin concentration time consuming and not suitable for em er g ency testing. above the upper reference limit is normally caused by A latox agglutination assay (5> 10) gives only semithe injury of cardiac muscle, e. g. acute myocardial m-quantitative results and is less sensitive. The aim of our farction, provided skeletal muscle has been excluded äs study was to evaluate a new fast ^ quantitative turbidia sotirce. In addition, physical exercise (2) or decreased metric assay for det ermination of myoglobin and to renal function with subsequent decreased myoglobin test the diagil ostic relevance in the early phase of acute clearance can result in elevated myoglobin levels in myocard jai infarction. blood (3) . After aoute myocardial infarction, myoglobin is rapidly released from necrotic myocardium in advance of cytoplasmic enzymes such äs creatine kinase ( (EC 2.7.3.2) 1
Materials and Methods
.Refcrence individuals and patients Sera vvere obtained from -100 patients vvith elevated creatine kinase levels; reference limits in this laboratory are 80 U/l for male and 70 U/l for female(ll),
-100 apparently healthy persons (50 males and 50 females) to determine the reference interval.
-18 patients with acute myocardial infarction (at admission and at defmite times after onset of ehest pain); acute myocardial infarction was confirmed with typical changes in ECG and courses of creatine kinase and creatine kinase-MB.
Furthermore, two plasma samples with K-ethylenediaminetetraacetate (EDTA) and Na-citrate s an anticoagulant were collected from 20 individuals.
All specimens were analysed within 24 hours after venipuncture. The specimens from the 18 patients with acute myocardial infarction were stored at -20 °C until analysis.
Immunoturbidimetric method
The determination of serum and plasma myogiobin was performed using the TurbiTimeSystem (Behringwerke AG, Marburg, Germany), a turbidimetric immunoassay for the single testing of plasma proteins. The calibration Information needed for the assay is charge-dependent and inserted s a bar code in the package Information. For measurement of myogiobin, a cuvette is filled with 50 μΐ of undiluted serum or plasma, inserted into the System, and 500 μΐ reagent solution (Turbiquant Myogiobin, code No. QWNK, Behringwerke AG) is added. The test result is presented within 2 minutes. The pre-programmed measuring r nge lies between 50 and 650 μg/l.
Immunonephelometric method
The BNA System (Behringwerke AG) is a fully automated System for immunonephelometric examination of plasma proteins. Myogiobin measurement is carried out with latex particles coated with anti-myoglobin antibodies (NA-Latex Myogiobin Test, Behringwerke AG) (9) . The measuring r nge extends frorn 21.9 to 350 μg/l with a coefficient of Variation of 10% at 100 μg/l.
Creatine kinase and creatine kinase-MB Creatine kinase and creatine kinase-MB were determined using dry-film technology on a fully automated analyser (Ektachem 700XR, Eastman Kodak, Rochester, NY). The coefficients of Variation were 4.1% for creatine kinase at 100 U/l and 4.9% for creatine kinase-MB at 36 U/l.
Evaluation
Evaluation was performed according the recommendations of Singer et al. (12) . All measurements were performed in duplicate.
Statistical analysis
Correlations were calculated by linear regression analysis.
Results

Imprecision
Three different pooled human sera with elevated myo-°g lobin concentrations and a commercial control serum (Behringwerke AG, Marburg, Gennany) were analysed 10 times to estimate intra-assay imprecision (tab. 1). For inter-assay reproducibility all controls were tested over 50 coiisecutive days (tab. 1).
Linearity
The linearity of dilution was investigated using serum samples containing high myogiobin concentrations. Seri l dilutions (10+0, 9+1, ..., 0+10) were made with NaCl or enzyme diluent. Figure l shows the res lts of serial dilution of one of these serum samples. After correction of the measured value for the dilution factor, recovery was found to be between 81 and 101% using NaCl, and 88 and 101% using enzyme diluent to dilute the myogiobin conceritration of undiluted samples (tab. 2).
Interfering s bstances
Sera containing potential interfering s bstances were added to myoglobin-rich serum samples in different ra- Tab. 2 Dilution of myoglobin-containing serum samplcs with enzyme diluent and NaCl. Shown is the percentual deviation from the theoretical value for every dilution Step.
Myoglobin recovery (% ± s) Diluent Diluent sample -f diluent NaCl Effect of probe Figure 3 shows the comparison of serum vs. EDTA-and citrate-plasma. In both plasmas, the amount of myoglobin measured is less than that found in serum; the EDTA plasma showed only 92% of the actual myoglobin concentration, and the citrate plasma 89%. 
Stability
Ten serum samples were divided into aliquots and stored either at room temperature for 2 days, at H-4 °C for one week or at -20 °C at least 3 months. In contrast to fresh samples, no alteration in myoglobin concentration was found (tab. 3).
Reference values Figure 4 shows the cumulative distribution of the myoglobin concentration in the serum samples of the reference population. The upper reference limit (97.5% percentile) was found to be 61. ric assay were re-evaluated using immunonephelometry. The following correlation was obtained: y=1.02x + 5.53, r = 0.982 ( fig. 5 ).
Diagnostic implications
To investigate the diagnostic implication of myoglobin determination in the early phase ofacute myocardiial in-· farction, serum samples were collected from 18 patients with proven acute myocardial infarction at admission and at 2, 4, 6, 9, 12, 15, 18 and then every 6 hours for at least 60 hours after onset of ehest pain. Myoglobin concentration and creatine kinase activity were measured in all samples. Figure 6 and 7 summarize the time courses of creatine kinase activity and myoglobin concentration of all 18 patients. Myoglobin appeared at con·? centrations above the upper reference limit on average 2.9 ±1.7 hours after onset of ehest pain. In contrast, creatine kinase activity above the upper reference limit was first observed on average 5.3 ± 2 hours after acute myocardial infarction. The peak value for myoglobin was reached 4.8 ±3.2 hours after acute myocardial infarction, for creatine kinase activity at 15.2 ± 7.4 hours. At 23.9 ± 13.8 hours after onset of ehest pain, myoglobin concentration returned to within the reference interval, whereby 7 patients showed a so called "staccato phenomenon" (13) . Creatine kinase activity retumed to the normal r nge on average 51.7 ± 15.6 hours after acute myocardial infarction, during which time six patients showed a second pe lk.
Elevated myoglobin or creatine kinase activity levels * alone are insufficient for the diagnosis of acute myocardial infarction. Therefore, it-is mecessary to determine the level in a second, independent sample approximately one hour later to confirm that it displays a significant increase compared with the starting value. Figure 8 and 9 show creatine kinase activity and myoglobin concentration in the first two blood collections for each patient. In the first sample, the myoglobin concentration He äbove the upper reference limit for all patients. In one patient the second value is, however decreased compared with the first. In 10 patients, both values of creatine kinase activity are within the reference limit, but in all 18 patients the second value is higher than the first.
Discussion
Evaluation
As described under results, the TurbiTimeSystem is a fast, reliable and simple method for the quantitative determination of myoglobin concentrations in serum. In-
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soo Ist sample 2nd sample Fig. 8 Comparison of the creatine kinase concentrations of the first two blood samples in all 18 patients after acute myocardial infarction.
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Ist sample 2nd sample Fig. 9 Comparison of the myoglobin concentrations of the first two blood samples in all 18 patients after acute myocardial infarction.
tra-assay and inter-assay imprecision is low and compaxability with immunonephelometry is good. With the exception of triacylglycerol, potentially interfering substances do not disturb the assay. Similar results were obtained by Delanghe et al. (14) and Mair et al. (15), but correlation with RIA was inferior. Lipid extraction using an extraction agent leads to an underestimation of myoglobin of up to 36% (14) . This can be avoided using brief ultracentrifugation.
Myoglobin levels in serum are in general higher than in EDTA-or citrate-treated plasma samples, but the lower results for citrate plasma are primarily dependent on the dilution factor. Therefore, reference ranges for each type of material are necessary. For serum myoglobin, we found an upper reference limit of 61. (14) who found sex-related reference limits of 68.6 g/l for females and 74.1 g/l for males. In conclusion, the immunoturbidimetric determination of myoglobin is a viable alternative to other quantitative assays. Its advantages are that it is a fast, reliable method and thus suitable for an emergency laboratory or small laboratory units.
Diagnostic significance
In the early phase of acute myocardial infarction there are no differences in the predictive value of myoglobin concentration or creatine kinase activity (l, 5, 8, 16) . As only a semi-quantitative latex-test for determination of myoglobin was hitherto available (5, 10), it was not practicable to determine myoglobin concentration in emergency situations. The TurbiTimeSystem permits the rapid, quantitative determination of myoglobin concentration. This raises afresh the question of whether the determination of myoglobin concentration is superior to creatine kinase aetivity in the early phase diagnosis of acute myocardial infarction.
Both quantities have the same tissue distribution, above all in skeletal and cardiac muscle (l, 17). In addition, physical exercise or disease affecting skeletal muscles (2) äs well äs decreased renal function will lead to an increased myoglobin concentration (3). Taking these factors ihto consideration and the dynamics of tissuerelease and clearance, both analytes can be recruited in the diagnosis of acute myocardial infarction.
Our findings indicate that myoglobin, in comparison with creatine kinase, shows earlier values above the upper reference limit (2.9 vs. 5.3 hours) in concordance with other data (15 a & b, 18, 19, 20) . The concentration peaks much earlier (4.8 vs. 15.2 hours) and myoglobin returns to the normal ränge earlier than creatine kinase (23,9 vs. 51.7 hours). Because the molecular mass of myoglobin is lower than that of creatine kinase, it appears before creatine kinase in the blood stream and is rapidly cleared through the kidneys. On the other band, our investigations show that creatine kinase activity rises in all patients with acute myocardial infarction in two consecutive blood samples, even if the second value for creatine kinase in 10 out of 18 patient lies within the normal ränge (flg. 7). In contrast, the second myoglobin sample of patient even showed a decreased value ( fig. 8) .
Therefore, both quantities have equal significance in the diagnosis of acute myocardial infarction. In the first hours after the onset of ehest pain, myoglobin has a diagnostic advantage äs it is released into the blood stream earlier than creatine kinase. If the first blood sample from patients with acute myocardial infarction is taken later than 4 hours after onset of ehest pain, myoglobin can lead to false negative diagnosis. For this reason, the simultaneous determination of creatine kinase and its isoenzyme creatine kinase-MB is still the diagnostic strategy of choice for the diagnosis of acute myocardial infarction (4) . On the other hand, in monitoring thrombolysis therapy of acute myocardial infarction, the determination of myoglobin in superior to creatine kinase. As myoglobin is rapidly released after successM thrombolysis into the blood, increasing values of myoglobin show effective recanalisation within a few hours (20) .
Recently, a new, fast system that makes use of "dry chemistry" procedüres has been made available (OPUS, Behringwerke AG, Marburg, Germany). Whether or not this new technology is superior to turbidimetry äs a fast technique for emefgency use has yet to be demonstrated.
